Electroactive Molecularly Imprinted Polymer Nanoparticles (eMIPs) for Label‐free Detection of Glucose: Toward Wearable Monitoring
Small · 2024
DOI: 10.1002/smll.202403320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Saweta Garg und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, The University of Manchester, Engineering building A, East Booth Street, Oxford Road, Manchester, M13 9PL, UK. Hauptthemen laut MEDLINE: Nanoparticles, Wearable Electronic Devices, Polymers, Glucose. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Northern Accelerator grant, Medical Research Council.
Abstract (Originalsprache)
The diagnosis of diabetes mellitus (DM) affecting 537 million adults worldwide relies on invasive and costly enzymatic methods that have limited stability. Electroactive polypyrrole (PPy)‐based molecularly imprinted polymer nanoparticles (eMIPs) have been developed that rival the affinity of enzymes whilst being low‐cost, highly robust, and facile to produce. By drop‐casting eMIPs onto low‐cost disposable screen‐printed electrodes (SPEs), sensors have been manufactured that can electrochemically detect glucose in a wide dynamic range (1 µ m –10 m m ) with a limit of detection (LOD) of 26 n m . The eMIPs sensors exhibit no cross reactivity to similar compounds and negligible glucose binding to non‐imprinted polymeric nanoparticles (eNIPs). Measurements of serum samples of diabetic patients demonstrate excellent correlation (>0.93) between these eMIPs sensor and the current gold standard Roche blood analyzer test. Finally, the eMIPs sensors are highly durable and reproducible (storage >12 months), showcasing excellent robustness and thermal and chemical stability. Proof‐of‐application is provided via measuring glucose using these eMIPs sensor in a two‐electrode configuration in spiked artificial interstitial fluid (AISF), highlighting its potential for non‐invasive wearable monitoring. Due to the versatility of the eMIPs that can be adapted to virtually any target, this platform technology holds high promise for sustainable healthcare applications via providing rapid detection, low‐cost, and inherent robustness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering, The University of Manchester, Engineering building A, East Booth Street, Oxford Road, Manchester, M13 9PL, UK.
- School of Engineering, Newcastle University, Newcastle upon Tyne, NE1 7RU, UK.
- Department of Chemistry, Centre for Advanced Studies, Guru Nanak Dev University, Amritsar, Punjab, 143005, India.
- Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, M1 5GD, UK.
ORCID-Profile: Marloes Peeters
Förderung
- Northern Accelerator grant
- Medical Research Council
Zitieren
APA
Garg, S., Singla, P., Kaur, S., Crapnell, R. D., Banks, C. E., Seyedin, S., & Peeters, M. (2024). Electroactive Molecularly Imprinted Polymer Nanoparticles (eMIPs) for Label‐free Detection of Glucose: Toward Wearable Monitoring. Small. https://doi.org/10.1002/smll.202403320
Vancouver
Garg S, Singla P, Kaur S, Crapnell RD, Banks CE, Seyedin S, et al. Electroactive Molecularly Imprinted Polymer Nanoparticles (eMIPs) for Label‐free Detection of Glucose: Toward Wearable Monitoring. Small. 2024. doi:10.1002/smll.202403320
BibTeX
@article{Garg2024,
author = {Garg, Saweta and Singla, Pankaj and Kaur, Sarbjeet and Crapnell, Robert D and Banks, Craig E and Seyedin, Shayan and Peeters, Marloes},
title = {Electroactive Molecularly Imprinted Polymer Nanoparticles (eMIPs) for Label‐free Detection of Glucose: Toward Wearable Monitoring},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202403320}
}
EUVIMED